Indications for Use
The MCS+ LN9000 system is intended for use as an automated cell separator system and blood component collector in conjunction with the Single Donor Platelets Protocol and single use sterile disposable sets. Products that can be collected using the MCS+ LN9000 include single donor platelets with or without concurrent plasma, and for those products collected with the LN994CF, leukocyte reduced platelets.
The MCS+ 9000 system with wireless capable modification is intended for use as an automated blood cell separator system and blood component collector in conjunction with single use sterile disposable sets. Products that can be collected using the MCS+ 9000 System include single donor platelets and concurrent plasma.
The LN994 is a functionally closed system intended to be used to collect one unit of Platelets, Pheresis with or without Plasma, or two units of Platelets Pheresis from donors using the MCS+ LN9000.
The LN994CF and LN994CF-CPP are functionally closed systems intended to be used to collect one unit of Platelets, Pheresis Leukocyte Reduced with or without Plasma, or two units of Platelets, Pheresis, Leukocyte Reduced from donors using the MCS+ LN9000.
The indications for use for the wireless capable modified MCS+ 9000 system are the same as the currently marketed MCS+ 9000 System.
The Haemonetics extended Storage Platelet and Plasma Set with Saline Compensation, PALL filter (LRF-XL), is intended to be used to collect one unit of platelets, leukocyte reduced (with or without plasma). Additionally, the set may be used to collect two units of platelets, leukocyte reduced. The collected platelets may be stored up to 7 days when collected using the LN994CF-CPP and coupled with 100% screening for bacterial contamination with a device cleared for that purpose with its recommended method prior to transfusion.
Please refer to the manual for indications for use, contraindications, warnings, precautions and potential adverse events.